Natalya (Desogestrel, Ethinylestradiol)

Desogestrel/Ethinylestradiol, the active ingredient in Natalya, is a combined oral contraceptive presented as a tablet for oral use. It works by inhibiting ovulation and altering cervical mucus and endometrial lining, thereby preventing fertilization and implantation in women of reproductive age who seek reliable pregnancy prevention.

GNH USA supplies Natalya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality‑assured products that meet EU regulatory standards. Our distribution network provides reliable logistics and regulatory support for global customers.

Natalya, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy.

- Prevention of pregnancy: provides reliable contraception for women of childbearing age. - Menstrual cycle regulation: helps establish regular bleeding patterns. - Acne improvement: may reduce acne severity associated with hormonal fluctuations.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary soreness or swelling. - Headache: occasional tension‑type headache. - Spotting: irregular bleeding between periods. - Weight gain: modest fluid retention. - Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke: cerebrovascular accident risk. - Myocardial infarction: heart attack in susceptible individuals. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver tumor: rare hepatic adenoma development.

Before prescribing Natalya, clinicians should consider several safety factors. - Pregnancy contraindication: not for use in pregnancy (Category X). - Smoking restriction: avoid in women over 35 who smoke. - Cardiovascular risk: assess history of thromboembolism or clotting disorders. - Liver disease: use with caution in hepatic impairment. - Drug interaction review: evaluate concomitant medications that may affect efficacy. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture and direct sunlight.

Natalya may interact with several medicines; monitoring is essential.

Major Interactions (Avoid): - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce contraceptive effectiveness. - Anticoagulants (e.g., warfarin): hormonal changes can alter clotting parameters. - Certain antiretrovirals (e.g., efavirenz): may diminish hormone levels.

Moderate Interactions (Monitor Closely): - Antifungals (e.g., ketoconazole): can increase hormone concentrations. - SSRIs (e.g., fluoxetine): may increase risk of bleeding. - St. John’s wort: may lower contraceptive efficacy.